aTyr Pharma | LIFE - Ativo Circulante





Ativo Circulante Alterar Data
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Ardelyx USD 381.87M 447K 2026-03
aTyr Pharma USD 67.58M 178.23M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Cipla INR 241.47B 7.71B 2026-03
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 137.28M 10.74M 2026-03
CSL USD 11.85B 1000K 2025-12
Curis USD 6.92M 7.5M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
United Therapeutics USD 2.87B 830.5M 2026-03
Xoma USD 110.71M 5.78M 2025-09